Hyderabad Telangana, India

Krishna Murthy Bhavanasi

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Natco Pharma Limited. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Krishna Murthy Bhavanasi: Innovator in Pharmaceutical Compositions

Introduction

Krishna Murthy Bhavanasi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pomalidomide compositions. His expertise and dedication to research have led to advancements that benefit the medical community.

Latest Patents

Krishna Murthy Bhavanasi holds a patent for pharmaceutical compositions of pomalidomide. This invention relates to compositions that comprise pomalidomide and a binder or filler, with the amount of these components being at most 89% weight percent of the total weight of the composition. The process for preparing such compositions is also detailed in his patent, showcasing his innovative approach to pharmaceutical development.

Career Highlights

He is currently associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his knowledge and skills in developing effective pharmaceutical solutions. His work has been instrumental in advancing the company's product offerings.

Collaborations

Some of his notable coworkers include Satyanarayana Vattikuti and Naveen Krishna Yalamanchalli. Their collaboration fosters a creative environment that encourages innovation and the development of new pharmaceutical products.

Conclusion

Krishna Murthy Bhavanasi's contributions to pharmaceutical compositions exemplify the impact of innovation in medicine. His work not only enhances the efficacy of treatments but also reflects the importance of collaboration in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…